Condition 1: Osteosarcopenic obesity syndrome. Condition 2: postmenopausal osteoporosis. Age-related osteoporosis without current pathological fracture
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age over 60 years Body fat percent over 32% or BMI over 30 T-score less than -1.0 Hand grip less than 21kg Skeletal mass index (SMI) less than %28
Exclusion criteria
Exclusion criteria: Having parallel physical exercises Following a weight loss diet of more than 5 kg in the last three months Chronic illness such as hypertension, thyroid or kidney problems, diabetes, cancer very severe osteoporosis Hormone therapy or any drug that affects bone density, adipose tissue, or the hormonal system.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Myostatin. Timepoint: 24 hours before the intervention and 48 hours after the end of the last training session. Method of measurement: Elisa Kit (Pack of 96).;Follistatin. Timepoint: 24 hours before the intervention and 48 hours after the end of the last training session. Method of measurement: Elisa Kit (Pack of 96).;Insulin-like growth factor 1(IGF-1). Timepoint: 24 hours before the intervention and 48 hours after the end of the last training session. Method of measurement: Elisa Kit (Pack of 96).;Fibroblast Growth Factor2(FGF-2). Timepoint: 24 hours before the intervention and 48 hours after the end of the last training session. Method of measurement: Elisa Kit( Pack of 96). | — |
Secondary
| Measure | Time frame |
|---|---|
| Bone Densitometry. Timepoint: One week Before the Intervention and one Week After the Last Training Session. Method of measurement: dual-energy X-ray absorptiometry (DXA).;Body Fat Percent. Timepoint: One week Before the Intervention and one Week After the Last Training Session. Method of measurement: Use the Harpernet model calipers. | — |
Countries
Iran (Islamic Republic of)
Contacts
The University of Shahrekord